Eli Lilly and Company (NYSE: LLY), a global pharmaceutical company, is going to cut about 500 jobs in order to rationalize manufacturing operations in Indianapolis.
The company will carry out the voluntary exit program mainly in the sphere of manufacturing, but will also include a small portion in areas of research and development.
The cuts will involve workers who manufacture ingredients for drugs Humalog, Humulin and Forteo.
The behavior of the Russian inspector satellite, which was launched in the autumn of 2017, puzzles military officials in the United States
Ukrainian bloggers draw a parallel between the events in East Timor and the Crimea. Any comparison has a right to exist, but a detailed analysis of the situation does not give a promising forecast to Ukraine
Vladimir Putin is planning to attend the wedding ceremony of Austria's Foreign Minister Karin Kneissl on the way to Berlin